Results 221 to 230 of about 690,479 (320)

Hepatocellular carcinoma. Review of 32 cases in childhood and adolescence [PDF]

open access: bronze, 1983
Ernest E. Lack   +2 more
openalex   +1 more source

HPD is an RNA‐Binding Protein Sustaining Ovarian Cancer Cell Glycolysis, Tumor Growth, and Drug Resistance

open access: yesAdvanced Science, EarlyView.
HPD is identified as an RNA‐binding protein that promotes mRNA translation by binding to RRACH motifs via its double‐stranded RNA‐binding domains. This RNA‐binding activity critically sustains glycolysis in ovarian cancer cells. Disrupting HPD's RNA‐binding function effectively suppresses tumor growth and enhances therapeutic sensitivity, highlighting ...
Fei Xie   +21 more
wiley   +1 more source

Prognosis of hepatocellular carcinoma smaller than 5 cm in relation to treatment: Study of 100 patients [PDF]

open access: bronze, 1987
Kunihiko Ohnishi   +11 more
openalex   +1 more source

Copper‐Based Nanotubes That Enhance Starvation Therapy Through Cuproptosis for Synergistic Cancer Treatment

open access: yesAdvanced Science, EarlyView.
We designed a copper‐based nanotube (NT) with copper ionophores to induce enhanced cuproptosis. In combination with starvation therapy, the NT significantly inhibited energy metabolism in HCC cells. Our results show that the depletion of GSH by Cu2+ intensified oxidative stress and cuproptosis, resulting in ROS generation and DLAT aggregation ...
Xuan Han   +8 more
wiley   +1 more source

Role of Vascular Liver Diseases in Hepatocellular Carcinoma Development. [PDF]

open access: yesCancers (Basel)
Giuli L   +7 more
europepmc   +1 more source

Hepatocellular carcinoma arising in noncirrhotic and highly cirrhotic livers: A comparative study of histopathology and frequency of hepatitis B markers [PDF]

open access: bronze, 1982
Kunio Okuda   +9 more
openalex   +1 more source

SF3A3 Drives Tumorigenesis in Endometrial Cancer by Enhancing c‐FOS Expression and Represents a Potential Therapeutic Target

open access: yesAdvanced Science, EarlyView.
The role of splicing factor 3A subunit 3 (SF3A3) in driving endometrial cancer (EC) progression and potential therapeutic interventions. SF3A3, a core component of the U2 small nuclear ribonucleoprotein (U2 snRNP), is upregulated in endometrial cancer (EC) and promotes tumor growth and cisplatin resistance. RNA‐binding protein immunoprecipitation (RIP)
Wei Yu   +13 more
wiley   +1 more source

Profiling of the tumor-associated microbiome in patients with hepatocellular carcinoma. [PDF]

open access: yesGut Pathog
Schulz C   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy